AmorChem invests in a new university gene therapy project

AmorChem has made an investment in a university project that will focus on a new gene therapy to help patients with retinal degeneration.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this